Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ascending multiple-dose tigecycline in children with serious infections
2007-002120-14Phase 2Completed
- Sponsor
- Wyeth
- Start
- Aug 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tigecycline in Intra-abdominal infection (IAI), Complicated skin and skin structure infection (cSSSI) and community-acquired pneumonia (CAP), sponsored by Wyeth. Primary endpoints: Pharmacokinetic profile of tigecycline and Safety and tolerability of tigecycline. Started Aug 2008; status: completed.
02
Drugs
tigecycline
03
Conditions
Intra-abdominal infection (IAI)Complicated skin and skin structure infection (cSSSI)community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on 2007-002120-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002120-14.